Cite

    Chupin, A. et al. (2020). Systematic review with meta‐analysis: comparative risk of lymphoma with anti‐tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics. 52 (8), pp. 1289-1297. [Online].